ELKHART GENERAL HOSPITAL — History
CCN 150018 | 3-year financial timeline | COVID resilience: 35/100
🛡️ Public data only — no PHI permitted on this instance.
$323M
Latest Revenue (FY2022)
+6.9%
Revenue CAGR (3yr)
-1.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $283M | $320M | $323M | +0.9% | +6.9% |
| Operating Expenses | $263M | $308M | $326M | +5.9% | +11.3% |
| Operating Margin | 6.7% | 3.8% | -1.0% | -125.1% | +0.0% |
| Net Income | $19M | $12M | $-3M | -125.3% | +0.0% |
| Licensed Beds | 241 | 215 | 201 | -6.5% | -8.7% |
| Total Patient Days | 47,120 | 51,145 | 50,432 | -1.4% | +3.5% |
| Medicare Day % | 33% | 29% | 28% | -3.7% | -8.8% |
| Medicaid Day % | 3% | 4% | 4% | +17.7% | +12.3% |
COVID Impact & Recovery
Resilience Score: 35/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +14.3% ($283M → $323M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.9%
This Hospital
+7.6%
State Avg
Latest Margin
-1.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $343M | -4.8% |
| FY2024 (proj) | $363M | -8.7% |
| FY2025 (proj) | $384M | -12.5% |